Medicure is a pharmaceutical company focused on the development and commercialization of cardiovascular therapeutics for the U.S. market
Medicure's vision is to become a leading cardiovascular pharmaceutical company within the U.S, offering a growing product portfolio of cardiovascular products that improve patients' lives. We have an unwavering focus on delivering safe, efficacious and cost-effective medicines that benefit patients, healthcare providers and shareholders. Our commitment to service, partnership and integrity is what sets us apart.
Medicure was established in 1997, and spent its first decade focused on research and development. In 2008, the company began a transition to focus on its commercial pharmaceutical business. This new direction has provided significant shareholder value with the growth of Aggrastat® (tirofiban hydrochloride) sales, achieving profitability, and the pursuit of development and acquisition opportunities.
member
02/28/2023 00:00:00
Job Summary:
The Pharmaceutical Account Executive is responsible for working in a dedicated area/region to promote Medicure portfolio products with the end goal of establishing sales and relationships with hospitals, pharmacies and doctor’s offices.
Du…
02/28/2023 00:00:00
Job Summary:
The Project and Logistics Manager will manage manufacturing and development of Medicure’s products, as assigned. This position will require cross-department collaboration with Regulatory, Scientific Affairs and Quality departments, reportin…
Seven Oaks Capital Corp.is pleased to announce that it has entered into a binding letter agreement dated January 29, 2023 (the "Definitive Agreement") with Rimon Hedge Funds Ltd.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.